Middle East and Africa Active Pharmaceutical Ingredients (API) Market - Industry Trends and Forecast to 2028

Segmentation

Short Description
Middle East and Africa Pharmaceutical Ingredients (API) Market, By Molecule (Small Molecule, Large Molecule), Type (Innovative Active Pharmaceutical Ingredients, Generic Innovative Active Pharmaceutical Ingredients), Type of Manufacturer (Captive API Manufacturer, Merchant API Manufacturer), Synthesis (Synthetic Active Pharmaceutical Ingredients and Biotech Active Pharmaceutical Ingredients), Chemical Synthesis (Acetaminophen, Artemisinin, Saxagliptin, Sodium Chloride, Ibuprofen, Losartan Potassium, Enoxaparin Sodium, Rufinamide, Naproxen, Tamoxifen, Others), Type of Drug (Prescription Drugs, Over-the-Counter), Usage (Clinical, Research), Potency (Low-to-Moderate Potency Active Pharmaceutical Ingredients, Potent-to-Highly Potent Active Pharmaceutical Ingredient), Therapeutic Application (Cardiology, CNS & Neurology, Oncology, Orthopedic, Endocrinology, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, Other Therapeutic Application), Country(Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Definition:
The tradition word for active pharmaceutical ingredients (API) that is in Greek is called as pharmacon or pharmakon which symbolizes magical substance or drug.  Active pharmaceutical ingredients as described in ICH Q7 is any substance or combination of substances intended to be used in the manufacture of a drug product, which when used in production of drug, becomes an active pharmaceutical ingredients. Such substances is used to provide pharmacological activity. When more than one APIs is added in the drug then it produces various therapeutic activity and can be used for the treatment of various diseases and control their symptoms. A small amount of active pharmaceutical ingredient is effective to provide a therapeutic effect in the body. The active pharmaceutical ingredients goes under chemical changes during the manufacturing of the APIs and then it is present in the finished drug product in a modified form to provide a specific therapeutic effect.
Market Segmentation:
The active pharmaceutical ingredients (API) market is segmented on the basis of the molecule, type, type of manufacturer, synthesis, chemical synthesis, type of drug, usage, potency and therapeutic application.
 On the basis of molecule, the active pharmaceutical ingredients (API) market is segmented into small molecule and large molecule
 On the basis of type, the active pharmaceutical ingredients (API) market is segmented into innovative active pharmaceutical ingredients and generic active pharmaceutical ingredients
 On the basis of type of manufacturer, the active pharmaceutical ingredients (API) market is segmented into captive API manufacturer and merchant API manufacturer
 On the basis of synthesis, the active pharmaceutical ingredients (API) market is segmented into synthetic active pharmaceutical ingredients and biotech active pharmaceutical ingredients
 On the basis of chemical synthesis, the active pharmaceutical ingredients (API) market is segmented into acetaminophen, artemisinin, saxagliptin, sodium chloride, ibuprofen losartan potassium, enoxaparin sodium, rufinamide, naproxen, tamoxifen and others
 On the basis of type of drug, the active pharmaceutical ingredients (API) market is segmented into prescription drugs and over-the-counter drugs
 On the basis of usage, the active pharmaceutical ingredients (API) market is segmented into clinical and research
 On the basis of potency, the active pharmaceutical ingredients (API) market is segmented into low-to-moderate potency active pharmaceutical ingredients and potent-to-highly potent active pharmaceutical ingredient
 On the basis of therapeutic application, the active pharmaceutical ingredients (API) market is segmented into cardiology, CNS & neurology, oncology, orthopedic, endocrinology, pulmonology, gastroenterology, nephrology, ophthalmology and other therapeutic application

Market Players:

The key market players for Middle East and Africa active pharmaceutical ingredients (API) market are listed below:

 Sun Pharmaceutical Industries Ltd.
 Pfizer Inc.
 Dr. Reddys Laboratories Ltd.
 Cipla Inc.
 Teva Pharmaceuticals Industries Ltd.
 Sanofi
 GlaxoSmithKline plc
 Recipharm AB
 LUPIN
 Aurobindo Pharma
 Alembic Pharmaceuticals Limited
 AbbVie Inc.
 Alkem Labs
  Albemarle Corporation
  Unichem Laboratories
 AstraZeneca
 Merck KGaA
 Novo Nordisk A/S
 Sandoz International GmbH  (a subsidiary of Novartis AG)

Methodology